Table of Contents
1 Industry Outlook 8
1.1 Market Overview 8
1.2 Total addressable market 8
2 Report Outline 10
2.1 Report Scope 10
2.2 Report Summary 10
2.3 Research Methodology 11
2.4 Report Assumptions 12
3 Market Snapshot 13
3.1 Market Definition - Infoholic Research 13
3.2 Advantages of next-generation sequencing 13
3.3 Segmented Addressable Market (SAM) 13
3.4 Trends of the next-generation sequencing market 13
3.5 Related Markets 14
3.5.1 Polymerase chain reaction (PCR) 14
3.5.2 In-situ Hybridization 15
3.5.3 Microarray 15
4 Market Outlook 16
4.1 Market segmentation 16
4.2 PEST Analysis 16
4.3 Porter 5(Five) Forces 17
5 Market Characteristics 19
5.1 DRO - Global Next-generation sequencing Market Dynamics 19
5.1.1 Drivers 19
5.1.1.1 Usage of sequencing in wide range of diagnostic application 19
5.1.1.2 High speed' accuracy and reduced sequencing cost 20
5.1.2 Opportunities 21
5.1.2.1 Emerging applications of next-generation sequencing 21
5.1.2.2 Evolution of personalized medicine 21
5.1.3 Restraints 22
5.1.3.1 Complications associated with NGS data storage 22
5.1.3.2 Lack of skilled professional 22
5.2 DRO - Impact Analysis 23
5.3 Key Stakeholders 23
6 Technology: Market Size & Analysis 25
6.1 Overview 25
6.2 Reversible terminator sequencing 26
6.3 Ion semiconductor sequencing 27
6.4 Sequencing by ligation 27
6.5 Single molecule real-time (SMRT) sequencing 28
6.6 Nanopore sequencing 28
6.7 Others 29
7 Product: Market Size & Analysis 31
7.1 Overview 31
7.2 Instruments 32
7.3 Consumables and reagents 32
7.4 Services 32
8 Applications: Market Size & Analysis 34
8.1 Overview 34
8.2 Diagnostics 36
8.3 Biomarker discovery 37
8.4 Drug discovery 38
8.5 Agriculture and animal research 39
8.6 Other application 40
9 End-User: Market Size & Analysis 42
9.1 Overview 42
9.2 Hospital and reference laboratories 43
9.3 Academic and research institutions 43
9.4 Biotech and pharma companies 43
9.5 Others 44
10 Regions: Market Size and Analysis 45
10.1 Overview 45
10.2 North America 46
10.3 Europe 47
10.4 Asia Pacific 48
10.5 Rest of the World 50
11 Competitive Landscape 51
11.1 Overview 51
12 Vendor Profiles 54
12.1 Illumina' Inc. 54
12.1.1 Overview 54
12.1.2 Illumina' Inc.: Recent Developments 57
12.1.3 Business Units 62
12.1.4 Geographic Revenue 63
12.1.5 Business Focus 64
12.1.6 SWOT Analysis 64
12.1.7 Business Strategies 65
12.2 Thermo Fisher Scientific Inc. 65
12.2.1 Overview 65
12.2.2 Thermo Fisher Scientific Inc.: Recent Developments 66
12.2.3 Business Units 70
12.2.4 Geographic Presence 71
12.2.5 Business Focus 71
12.2.6 SWOT Analysis 72
12.2.7 Business Strategies 72
12.3 Pacific Biosciences of California' Inc. 73
12.3.1 Overview 73
12.3.2 Geographic Presence 76
12.3.3 Business Focus 76
12.3.4 SWOT Analysis 76
12.3.5 Business Strategies 77
12.4 Oxford Nanopore Technologies Ltd 78
12.4.1 Overview 78
12.4.2 Business Focus 79
12.4.3 SWOT Analysis 79
12.4.4 Business Strategies 80
12.5 Beijing Genomics Institute 81
12.5.1 Overview 81
12.5.2 Business Focus 82
12.5.3 SWOT Analysis 83
12.5.4 Business Strategies 83
13 Companies to Watch for 85
13.1 DNASTAR' Inc.' 85
13.1.1 Overview 85
13.2 Agilent Technologies' Inc. 86
13.2.1 Overview 86
13.3 Qiagen N.V. 91
13.3.1 Overview 91
13.4 Eurofins Scientific 95
13.4.1 Overview 95
13.5 Biomatters Limited 98
13.5.1 Overview 98
13.6 F. Hoffmann-La Roche 99
13.6.1 Overview 99
Annexure 102
? Acronyms 102